Mark J. Ratain to O(6)-Methylguanine-DNA Methyltransferase
This is a "connection" page, showing publications Mark J. Ratain has written about O(6)-Methylguanine-DNA Methyltransferase.
Connection Strength
0.260
-
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors. Clin Cancer Res. 2002 Aug; 8(8):2519-23.
Score: 0.208
-
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Clin Cancer Res. 2000 Aug; 6(8):3025-31.
Score: 0.045
-
Sequential therapy with dacarbazine and carmustine: a phase I study. Cancer Chemother Pharmacol. 1994; 34(6):509-14.
Score: 0.007